← Leaderboards
Bruce D Levy
Brigham And Women'S Hospital
$29,805,980
Attributed
$53,009,617
Total exposure
17
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.3M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$53,009,617 · 17
By mechanism
U01$17,276,351 · 1
R01$14,716,754 · 6
T32$8,419,164 · 1
U10$4,190,985 · 1
P01$3,673,001 · 2
U24$1,894,214 · 1
Top collaborators
- Elliot Israel16 shared
- Mario Castro8 shared
- Suzy Comhair8 shared
- Loren C Denlinger8 shared
- Eric A Hoffman8 shared
- Purveshkumar Khatri8 shared
- David T Mauger8 shared
- Deborah A. Meyers8 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Charles Nicholas Serhan$33,627,216
- Joel Voldman$6,954,416
- Susan S Redline$76,698,471
- Rui Wang$8,468,850
- Nicos A Petasis$6,738,732
Others in their field
Top investigators on “Inflammation”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$89,523,713
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Randall J Bateman · Washington University$64,707,456
- Peter Scott Heeger · Case Western Reserve University$56,547,884
Research focus
InflammationResponseResolutionCellsLungRespiratoryInflammatoryAnti-Inflammatory AgentsInsightMolecularMorbidity - Disease RateAirway InflammationLeukocytesBaseDesignAcuteSeveritiesAsthmaLipid MediatorMediator Of Activation ProteinNovel TherapeuticsGenerationsDoseRegulation
Grant awards (81)
Traffic-Related Ultrafine Particles Disrupt The Resolution Of Lung Inflammation$692,585
R01 · FY2025 · HL · contact PI
Integrated Training in Respiratory Research$453,512
T32 · FY2025 · HL
Integrated Training in Respiratory Research$828,764
T32 · FY2024 · HL
Traffic-Related Ultrafine Particles Disrupt The Resolution Of Lung Inflammation$732,085
R01 · FY2024 · HL · contact PI
Specialized Pro-Resolving Mediators in Asthma$721,062
R01 · FY2024 · HL · contact PI
Immunometabolic phenotypes in adult severe asthma and disease progression$3,233,979
U01 · FY2023 · HL · contact PI
Integrated Training in Respiratory Research$796,846
T32 · FY2023 · HL
Specialized Pro-Resolving Mediators in Asthma$734,091
R01 · FY2023 · HL · contact PI
Monitoring pro-resolving leukocyte responses in peripheral blood predicts clinical severity during sepsis$221,629
R21 · FY2023 · GM · contact PI
Immunometabolic phenotypes in adult severe asthma and disease progression$216,239
U01 · FY2023 · HL · contact PI
Immunometabolic phenotypes in adult severe asthma and disease progression$3,322,614
U01 · FY2022 · HL · contact PI
Integrated Training in Respiratory Research$777,838
T32 · FY2022 · HL · contact PI
Specialized Pro-Resolving Mediators in Asthma$735,776
R01 · FY2022 · HL · contact PI
EPHEDRA: Enhanced PHthisic by Environmental Disruptors of Resolution Agonists$510,710
R56 · FY2022 · ES · contact PI
Rapid saliva antigen test for SARS-CoV-2 detection$434,002
U01 · FY2022 · HL · contact PI
Monitoring pro-resolving leukocyte responses in peripheral blood predicts clinical severity during sepsis$237,799
R21 · FY2022 · GM · contact PI
Immunometabolic phenotypes in adult severe asthma and disease progression$235,989
U01 · FY2022 · HL · contact PI
Immunometabolic phenotypes in adult severe asthma and disease progression$3,058,207
U01 · FY2021 · HL · contact PI
Specialized Pro-Resolving Mediators in Asthma$753,841
R01 · FY2021 · HL · contact PI
Integrated Training in Respiratory Research$745,984
T32 · FY2021 · HL · contact PI
Immunometabolic phenotypes in adult severe asthma and disease progression$3,355,708
U01 · FY2020 · HL · contact PI
Integrate Training in Respiratory Research$473,495
T32 · FY2020 · HL · contact PI
Project 2: Specialized Pro-Resolving Mediators in the Resolution of Airway Injury$368,257
P01 · FY2020 · GM · contact PI
Immunometabolic phenotypes in adult severe asthma and disease progression$3,419,613
U01 · FY2019 · HL · contact PI
Integrate Training in Respiratory Research$703,207
T32 · FY2019 · HL · contact PI
Monitoring peripheral blood leukocyte and immune responses in health and disease$370,149
U24 · FY2019 · AI · contact PI
Project 2: Specialized Pro-Resolving Mediators in the Resolution of Airway Injury$368,257
P01 · FY2019 · GM · contact PI
Targeting MMP9 to Improve Outcomes in Serious Influenza Infections$850,154
R01 · FY2018 · AI
Integrate Training in Respiratory Research$680,985
T32 · FY2018 · HL · contact PI
Monitoring peripheral blood leukocyte and immune responses in health and disease$376,729
U24 · FY2018 · AI · contact PI
Project 2: Specialized Pro-Resolving Mediators in the Resolution of Airway Injury$331,428
P01 · FY2018 · GM · contact PI
Targeting MMP9 to Improve Outcomes in Serious Influenza Infections$955,998
R01 · FY2017 · AI
Integrate Training in Respiratory Research$662,496
T32 · FY2017 · HL · contact PI
Specialized Pro-Resolving Mediators in Asthma$429,790
R01 · FY2017 · HL · contact PI
Monitoring peripheral blood leukocyte and immune responses in health and disease$383,060
U24 · FY2017 · AI · contact PI
Project 2: Specialized Pro-Resolving Mediators in the Resolution of Airway Injury$368,243
P01 · FY2017 · GM · contact PI
AMSA: ALXR/FBR Mediated Signaling in Severe Asthma$714,183
U10 · FY2016 · HL
Integrate Training in Respiratory Research$653,242
T32 · FY2016 · HL · contact PI
Specialized Pro-Resolving Mediators in Asthma$429,790
R01 · FY2016 · HL · contact PI
Monitoring peripheral blood leukocyte and immune responses in health and disease$389,142
U24 · FY2016 · AI · contact PI
Project 2: Specialized Pro-Resolving Mediators in the Resolution of Airway Injury$372,652
P01 · FY2016 · GM · contact PI
AMSA: ALXR/FBR Mediated Signaling in Severe Asthma$695,606
U10 · FY2015 · HL
Specialized Pro-Resolving Mediators in Asthma$439,184
R01 · FY2015 · HL · contact PI
Integrate Training in Respiratory Research$421,083
T32 · FY2015 · HL · contact PI
Project 2 :Specialized Pro-Resolving Lipid Mediators$383,655
P01 · FY2015 · GM · contact PI
Monitoring peripheral blood leukocyte and immune responses in health and disease$375,134
U24 · FY2015 · AI · contact PI
AMSA: ALXR/FBR Mediated Signaling in Severe Asthma$708,154
U10 · FY2014 · HL
Integrate Training in Respiratory Research$621,352
T32 · FY2014 · HL · contact PI
Specialized Pro-Resolving Mediators in Asthma$427,095
R01 · FY2014 · HL · contact PI
Project 2 :Specialized Pro-Resolving Lipid Mediators$384,162
P01 · FY2014 · GM · contact PI
AMSA: ALXR/FBR Mediated Signaling in Severe Asthma$675,025
U10 · FY2013 · HL
Integrate Training in Respiratory Research$600,360
T32 · FY2013 · HL · contact PI
Project 2 :Specialized Pro-Resolving Lipid Mediators$326,680
P01 · FY2013 · GM · contact PI
AMSA: ALXR/FBR Mediated Signaling in Severe Asthma$709,100
U10 · FY2012 · HL
Lipoxins in Severe Asthma (LIPSA)$535,500
P50 · FY2012 · HL
Project 2 :Specialized Pro-Resolving Lipid Mediators$384,646
P01 · FY2012 · GM · contact PI
Counter-Regulatory Lipid Mediators in Lung Disease$303,188
R01 · FY2012 · HL · contact PI
AMSA: ALXR/FBR Mediated Signaling in Severe Asthma$688,917
U10 · FY2011 · HL
Lipoxins in Severe Asthma (LIPSA)$534,750
P50 · FY2011 · HL
Project 2 :Specialized Pro-Resolving Lipid Mediators$385,021
P01 · FY2011 · GM · contact PI
Counter-Regulatory Lipid Mediators in Lung Disease$306,250
R01 · FY2011 · HL · contact PI
Oxidative Stress and Anti-Inflammatory Lipids in Airway Disease$437,500
R01 · FY2010 · HL · contact PI
Lipid Mediators In The Resolution of Asthma Exacerbations$429,400
R56 · FY2010 · AI · contact PI
Counter-Regulatory Lipid Mediators in Lung Disease$306,250
R01 · FY2010 · HL · contact PI
Oxidative Stress and Anti-Inflammatory Lipids in Airway Disease$437,500
R01 · FY2009 · HL · contact PI
Counter-Regulatory Lipid Mediators in Lung Disease$306,250
R01 · FY2009 · HL · contact PI
Lipid Mediators in the Resolution of Asthma Exacerbations$511,877
R01 · FY2008 · AI · contact PI
Oxidative Stress and Anti-Inflammatory Lipids in Airway Disease$437,500
R01 · FY2008 · HL · contact PI
Counter-Regulatory Lipid Mediators in Lung Disease$297,644
R01 · FY2008 · HL · contact PI
Lipid Mediators in the Resolution of Asthma Exacerbations$522,303
R01 · FY2007 · AI · contact PI
Oxidative Stress and Anti-Inflammatory Lipids in Airway Disease$437,500
R01 · FY2007 · HL · contact PI
Lipid Mediators in the Resolution of Asthma Exacerbatio*$538,412
R01 · FY2006 · AI · contact PI
Counter-regulatory Lipid Signals in Lung Disease$295,636
R01 · FY2006 · HL · contact PI
Lipid Mediators in Resolution of Asthma Exacerbations$467,951
R01 · FY2005 · AI
Counter-regulatory Lipid Signals in Lung Disease$302,750
R01 · FY2005 · HL
Counter-regulatory Lipid Signals in Lung Disease$302,750
R01 · FY2004 · HL
Counter-regulatory Lipid Signals in Lung Disease$302,750
R01 · FY2003 · HL
Counter-regulatory Lipid Signals in Lung Disease$301,292
R01 · FY2002 · HL
NOVEL LUNG DERIVED CHALONES--BIOSYNTHESIS AND BIOACTIONS$123,120
K08 · FY2002 · HL
NOVEL LUNG DERIVED CHALONES--BIOSYNTHESIS AND BIOACTIONS$123,120
K08 · FY2001 · HL
NOVEL LUNG DERIVED CHALONES--BIOSYNTHESIS AND BIOACTIONS$123,120
K08 · FY2000 · HL